RemeGen CoREGMF -6.23%45 Shareholder Yield % is -1.21% as of Dec. 2025. GuruFocus rates REGMF with a GF Score™ of 45/100 and a GF Value™ of $18.73 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,296 Biotechnology companies, RemeGen Co ranks better than 50.77% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, RemeGen Co's Shareholder Yield % was -1.21%.
RemeGen Co (OTCPK:REGMF) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
RemeGen Co Shareholder Yield % Related Terms
RemeGen Co Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for RemeGen Co's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
REGMF vs VRTX, REGN, ALNY: Shareholder Yield % Comparison
For the Biotechnology subindustry, RemeGen Co's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RemeGen Co Shareholder Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, RemeGen Co's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where RemeGen Co's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
RemeGen Co (REGMF) has a Shareholder Yield % of -1.21% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on RemeGen Co and its competitors. According to the industry distribution chart, RemeGen Co ranks #638 out of 1296 companies in the Biotechnology industry, placing it in the top 49.2%.
Is RemeGen Co's Shareholder Yield % too high?
RemeGen Co's current Shareholder Yield % is -1.21%. Based on the distribution chart, RemeGen Co ranks #638 out of 1296 companies in the Biotechnology industry, which is above the industry midpoint. Overall, RemeGen Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RemeGen Co's Shareholder Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, RemeGen Co ranks #638 out of 1296 companies for Shareholder Yield %. This puts RemeGen Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on RemeGen Co and its competitors. RemeGen Co's current Shareholder Yield % is -1.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RemeGen Co stock overvalued right now?
Based on GuruFocus' analysis, RemeGen Co (REGMF) is currently considered Possible Value Trap. The stock's GF Value™ is $18.73, compared to a current price of $12.05 — trading 35.7% below its estimated fair value. The current Shareholder Yield % is -1.21%. RemeGen Co's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For RemeGen Co (REGMF), the current Shareholder Yield % is -1.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RemeGen Co (REGMF) Overvalued in 2026?
Based on GuruFocus' analysis, RemeGen Co stock appears to be undervalued.
The current stock price of $12.05 is trading 35.7% below its estimated GF Value™ of $18.73.
GuruFocus considers RemeGen Co to be Possible Value Trap.
Key valuation signals for REGMF:
Shareholder Yield %: -1.21%
GF Value™: $18.73 vs. price of $12.05 (35.7% below fair value)
No single metric tells the full story. See the REGMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat severe diseases such as autoimmune diseases, oncology, and ophthalmology. It has its operations in China and the USA and derives the majority of its revenue from China.
45GF Score
Get the complete analysis for REGMF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REGMF has been successfully added to your 
